Skip to main content

Advertisement

SpringerLink
Log in

Consultation-liaison psychiatry for patients with headaches

  • Migraine and Depression
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Screening of headache patients for psychiatric disorders is needed, because of the well-known high rates of comorbidity with depression and anxiety. Screening for both depression and anxiety is highly advisable in order to identify subjects who need psychiatric consultation and therapy. Screening tools for depression and anxiety range from informal questions to self-report instruments to structured interviews and the choice is up to the clinician and the setting of the clinical evaluation. Data on psychiatric disorders and medication overuse are till now not consistent. The treatment of mood and anxiety disorders in headache patients needs to take into account the possible drug interactions with headache therapies. The collaboration between neurologists and consultation-liaison psychiatrists helps the identification of headache patients who need a psychiatric therapeutic program and follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lipchik GL, Penzien DB (2004) Psychiatric comorbidities in patients with headache. Semin Pain Med 2:93–105

    Article  Google Scholar 

  2. Kalayadjian A, Merikangas K (2008) Physical and mental cmomorbidity of headache in a nationally representative sample of US adults. Psychosom Med 70:773–780

    Article  Google Scholar 

  3. Beghi E, Bussone G, D’Amico D et al (2010) Headache, anxiety and depressive disorder: the HADA study. J Headache Pain 11:141–150

    Article  PubMed  Google Scholar 

  4. Maizels M, Smitherman TA, Penzien DB (2006) A review of screening tools for psychiatric comorbidity in headache patients. Headache 46(s3):s98–s109

    Article  PubMed  Google Scholar 

  5. Borkum JM (2010) Chronic headaches and the neurobiology of somatization. Curr Pain Headache Rep 14:55–61

    Article  PubMed  Google Scholar 

  6. D'Amico D, Libro G, Prudenzano P et al (2000) Stress and chronic headache. J Headache Chronic Pain 1:S549–S552

    Google Scholar 

  7. Lake AE III, Rains JC, Penzien DB et al (2005) Headache and psychiatric comorbidity: historical context, clinical implications and research relevance. Headache 45:493–506

    Article  PubMed  Google Scholar 

  8. Pompili M, Di Cosimo D, Innamorati M, Lester D et al (2009) Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain 10:283–290

    Article  PubMed  Google Scholar 

  9. Kalaydjian A, Eaton W, Zandi P (2007) Migraine headaches are not associated with a unique depressive symptom profile: results from Baltimore Epidemiologic Cathment Area Study. J Psychosom Res 63:123–129

    Article  PubMed  Google Scholar 

  10. Smitherman TA, Maizels M, Penzien DB (2008) Headache chronification: screening and behavioural management of comorbid depressive and anxiety disorders. Headache 48:45–50

    Google Scholar 

  11. Aarre TF, Dahl AA (2008) Pharmacotherapy for bipolar depression: a review of the evidence. Curr Psychiatr Rev 4:145–156

    Article  CAS  Google Scholar 

  12. Holroyd KA, Labus JS, Carlson B (2009) Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain 143:213–222

    Article  PubMed  Google Scholar 

  13. Griffith JL, Razavi M (2006) Pharmachological management of mood and anxiety disorders in headache patients. Headache 46(s):s133–141

    Google Scholar 

  14. Dalton SO, Sørensen HT, Johansen C (2006) SSRIs and upper gastrointestinal bleeding. What is known and how should it influence prescribing? CNS Drugs 20(2):143–151

    Article  PubMed  Google Scholar 

  15. Wenzel RG, Tepper S, Korab WE (2008) Serotonine syndrome risk when combining SSRI/SNRI drugs and triptans:is the FDA’s alert warranted? Ann Pharmacother 42:1692–1696

    Article  PubMed  CAS  Google Scholar 

  16. Evans RW, Stewart JT, Shapiro RE et al (2010) The FDA alert on serotonine syndrome with use of triptans combined with selective serotonin inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American headache society position paper. Headache 50:1089–1099

    Google Scholar 

Download references

Conflict of interest

The authors declare that there is no actual or potential conflict of interest in relation to this article.

Author information

Authors and Affiliations

  1. DMCO, Università degli Studi di Milano, AO San Paolo, Via A. di Rudinì 8, 20100, Milan, Italy

    O. Gambini, B. Biagianti & S. Scarone

  2. AO San Paolo, Via A. di Rudinì 8, 20100, Milano, Italy

    V. Barbieri

Authors
  1. O. Gambini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Barbieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Biagianti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Scarone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Gambini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gambini, O., Barbieri, V., Biagianti, B. et al. Consultation-liaison psychiatry for patients with headaches. Neurol Sci 32 (Suppl 1), 81–83 (2011). https://doi.org/10.1007/s10072-011-0533-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-011-0533-4

Keywords

Search

Navigation